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The proteolytic processing of the viral polyprotein is an essential step during the life cycle of hepatitis A virus (HAV), as
it is in all positive-sense, single-stranded RNA viruses of animals. In HAV the 3C proteinase is the only proteolytic activity
involved in the polyprotein processing. The specific recognition of the cleavage sites by the 3C proteinase depends on the
amino acid sequence of the cleavage site. The structure of the complex of the HAV 3C proteinase and a dipeptide inhibitor
has been determined by X-ray crystallography. The double-mutant of HAV 3C (C24S, F82A) was inhibited with the specific
inhibitor iodoacetyl-valyl-phenylalanyl-amide. The resulting complex had an acetyl-Val-Phe-amide group covalently attached
to the Sg atom of the nucleophilic Cys 172 of the enzyme. Crystals of the complex of HAV 3C (C24S, F82A) acetyl-Val-Phe-
amide were found to be monoclinic, space group P21, having 4 molecules in the asymmetric unit and diffracting to 1.9-Å
resolution. The final refined structure consists of 4 molecules of HAV 3C (C24S,F82A) acetyl-Val-Phe-amide, 1 molecule of
DMSO, 1 molecule of glycerol, and 514 water molecules. There are considerable conformational differences among the four
molecules in the asymmetric unit. The final R-factor is 20.4% for all observed reflections between 15.0- and 1.9-Å resolution
and the corresponding Rfree is 29.8%. The dipeptide inhibitor is bound to the S91 and S92 specificity subsites of the proteinase.
The crystal structure reveals that the HAV 3C proteinase possesses a well-defined S92 specificity pocket and suggests that
the P92 residue could be an important determinant for the selection of the primary cleavage site during the polyprotein
processing in HAV. © 1999 Academic Press
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HINTRODUCTION
In all positive-sense, single-stranded RNA viruses that
nfect animals, the specific processing of the viral
olyprotein is a central step of the viral life cycle (Kra¨us-
lich and Wimmer, 1988). The viral polyprotein is gener-
ted by direct translation of the viral RNA genome. In the
iruses of the family Picornaviridae the polyprotein pro-
essing occurs cotranslationnally and is sequential (Pal-
enberg, 1990). Usually, the first cleavage during the
equential polyprotein processing separates the struc-
ural proteins from the other gene products (Ryan and
lint, 1997). In all picornaviruses, the 3C gene product
erforms the majority of the proteolytic cleavages that
iberate the individual viral gene products. The details of
he polyprotein processing differ among the six known
enera (Bergmann and James, 1999a). In the hepatovi-
uses, and presumably also in the viruses of the new
enus parechovirus, the 3C gene product is the only
roteolytic activity involved in polyprotein processing
nd cleaves all the specific cleavage sites within the viral
1 Current address: Schering-Plough Research Institute, 2015 Gallop-
ng Hill Road, Kenilworth, NJ 07033.
2 To whom correspondence and reprint requests should be ad-
oressed. Fax: (780) 492-0886. E-mail: Michael.James@ualberta.ca.
153olyprotein (Graff et al., 1999; Harmon et al., 1992; Jia et
l., 1993; Martin et al., 1995, 1999; Schultheiss et al., 1994,
995a, 1995b; Stanway and Hyypia¨, 1999).
The picornaviral 3C proteinases are related to the
hymotrypsin-like serine proteinases (Gorbalenya and
nijder, 1996). However, the 3C proteinases are cysteine
roteinases; the nucleophile is the sulfur atom of a cys-
eine residue within the conserved two-domain b–barrel
tructure of the chymotrypsin-like enzymes (reviewed by
ergmann and James, 1999b; Gorbalenya and Snijder,
996; Ryan and Flint, 1997).
Specific recognition of the cleavage sites within the
iral polyprotein by the 3C proteinase depends on the
mino acid sequence of the cleavage site. Cleavage
ites within the picornaviral polyprotein are typically
haracterized by the sequence of the four residues pre-
eding the scissile peptide bond and the two residues
ollowing it (Seipelt et al., 1999, and references therein).
e use the nomenclature of Schechter and Berger (1967)
o describe the interactions of the peptide substrate
equence with the specificity subsites in the active site
f the proteinase. P4P3P2P1uP91P92 represents the residues
f a specific substrate and S4 to S92 represent the corre-
ponding specific binding sites on the enzyme.
exapeptide substrates (P4 to P92) bind to the active site
f chymotrypsin-like proteinases in a canonical confor-
0042-6822/99 $30.00
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154 BERGMANN ET AL.ation (Bode and Huber, 1992; Perona and Craig, 1995;
ead and James, 1986). As a result of this main chain
onformation the side chains of several residues point
nto specificity pockets on the surface of the enzyme. The
icornaviral 3C proteinases possess well-defined S4, S2,
nd S1 specificity pockets (Bergmann et al., 1997; Mat-
hews et al., 1994; Mosimann et al., 1997). The side
hains of the P5 and P3 residues point away from the
ctive site into solvent. This correlates well with the fact
hat the 3C cleavage sites within picornaviral polypro-
eins can be identified by the residues in the P4, P2, and
1 positions (Seipelt et al., 1999). In addition, rhino- and
nteroviral 3C proteinases show preferences for a gly-
ine residue in the P91 position of a substrate.
Cocrystal structures of picornaviral 3C proteinases
ith inhibitors specifically directed against the P4- to
1-specific subsites confirmed that these substrate res-
dues are indeed bound in the canonical conformation
ound in chymotrypsin-like proteinases (Dragovich et al.,
998a,b; Webber et al., 1998). Furthermore, prior to the
lucidation of any cocrystal structure of a 3C proteinase
nhibitor complex, models of substrate binding, based on
his conformation, could successfully explain the speci-
icities of 3C proteinases (Bergmann et al., 1997; Mat-
hews et al., 1994; Mosimann et al., 1997). These models
id not predict the specific interactions, if any, of the P9
esidues of a substrate. In all the inhibitor cocrystal
tructures of 3C proteinases published so far, the spe-
ific interactions of the inhibitor and the enzyme are with
he P5 to P1 sites or less. No small-molecule inhibitor
ocrystal structure for any chymotrypsin-like proteinase
eveals binding to the P9 sites and the conformation in
hich the P9 residues bind to these proteinases can only
e inferred from cocrystal structures with large protein
nhibitors (Bode and Huber, 1992; Read and James, 1986).
Typical cleavage sites of the 3C proteinases from
epatitis A virus (HAV) are distinguished by a consensus
equence L/IX
S/TQuXX (reviewed by Bergmann, 1998, and
eipelt et al., 1999). The most important determinant is
he glutamine residue in the P1 position. Two of the
roposed cleavage sites within the HAV polyprotein have
P1 glutamate residue. These two cleavage sites (VP1uX
nd 3Au3B) have not been experimentally confirmed and
hese recognition sequences constitute poorer sub-
trates for the 3C proteinase (Jecht et al., 1998; Probst et
l., 1998). Recently, experimental evidence has been pre-
ented, demonstrating that VP1uX is not cleaved by the
C proteinase in HAV (Graff et al., 1999; Martin et al.,
999). It is also clear that the primary cleavage site of the
AV polyprotein, which separates the structural and non-
tructural proteins, is located at the N-terminus of the 2B
ene product and has the sequence GLFSQ_AKI (Jia et
l., 1993; Martin et al., 1995; Schultheiss et al., 1994,
995b). What determines the sequence of cleavages in
AV among the seven sites with glutamine in the P1
osition is not clear. Possibly the type of residue in the 1ther positions, including P91 and P92, contributes to the
etermination of the sequence of cleavages. The only
mino acid substitution, within the sequences of the
leavage sites of the HAV polyprotein, that distinguish a
aster-growing, cell culture-adapted HAV strain is a ly-
ine to asparagine mutation in the P92 position of the
rimary cleavage site of the viral polyprotein (Zhang et
l., 1995). Likely other factors that contribute to the de-
ermination of the sequence of cleavage events are the
ccessibility and the conformation of the cleavage sites
n the folded polyprotein.
Here we present the cocrystal structure of a covalent
omplex of the HAV 3C proteinase with an inhibitor, de-
igned to bind specifically to the S91 and S92 sites of the
nzyme (Mckendrick et al., 1998). The preferred dipeptide
equence was identified by incubating the enzyme with a
ixture of inhibitors and analyzing the result by mass spec-
roscopy. HAV 3C was able to select the tightest binding
nhibitor from the mixture, thereby providing evidence for
pecificity in the recognition of the P91 and P92 residues.
nfortunately, for technical reasons, it was not possible to
nclude all amino acids in each position of the dipeptide
nhibitor in the mixtures used (Mckendrick et al., 1998). The
est dipeptide sequences found from the inhibitors used
ere the sequences P91-P92 Ser-Phe and Val-Phe. The crystal
tructure reported here is for the inhibitor acetyl-valyl-phe-
yalanyl-amide covalently bound to the Sg atom of the
ucleophilic residue Cys172. The proteinase inhibitor com-
lex derives from the reaction of the nucleophilic thiol of the
roteinase with an iodoacetyldipeptide. The reaction was
xpected to be similar to the alkylation reaction of iodo-
cetamide with sulfhydryls in proteins. Confirmation of this
echanism of inhibition had been obtained by mass spec-
rometry prior to the elucidation of the crystal structure
Mckendrick et al., 1998).
Based on the details of the specific interactions be-
ween this dipeptide inhibitor and the specific subsites of
he HAV 3C proteinase, we propose a mechanism that
ontributes to the preferential recognition of the primary
leavage site within the HAV polyprotein.
RESULTS AND DISCUSSION
rystallization, structure solution, and refinement
Crystals of the HAV 3C acetyl-Val-Phe complex were
ound to belong to the monoclinic space group P21 and
o diffract to a maximum resolution of 1.9 Å. The statistics
f the diffraction data are shown in Table 1 and the
esults of the refinement are summarized in Table 2.
nitial electron density maps revealed a covalently bound
olecule of the inhibitor in the active site of each of the
our molecules, as had been expected from mass spec-
rospcopy of the inhibited enzyme (Mckendrick et al.,
998). The dipeptide inhibitors are bound in the same
ocation in each of the four independent molecules (Fig.
a). Fifteen cycles of manual rebuilding and computa-
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155INHIBITOR COMPLEX OF 3C PROTEINASE FROM HEPATITIS A VIRUSional refinement resulted in a final model consisting of
esidues A1 to A213, B1 to B217, C1 to C213, D1 to D217,
inhibitor molecules bound in the active sites of all 4
olecules, 1 molecule of DMSO, 1 molecule of glycerol,
nd 514 ordered water molecules. Residues 214–217 in
olecules A and C are presumably disordered and not
isible in the electron density maps. The results of the
efinement are summarized in Table 2. Representative
lectron density for the inhibitor bound in the active sites
f molecules D and B is presented in Figs. 1b and 1c.
ests during the refinement of the structure, in particular
he behavior of the free R-factor, indicated that restraints
or the noncrystallographic symmetry should not be ap-
lied.
The enzyme used in the present study is a double-
utant, C24S, F82A, that had been designed based on
he structure of the native enzyme. In the crystal structure
f native HAV 3C Phe 82 contributed to an intermolecular
nteraction in one of the two unique molecules of the
imer. In the other molecule within the asymmetric unit
imer the loop with Phe 82 was flexible and did not
articipate in any intermolecular interactions (Bergmann
t al., 1997). The enzyme for the crystal structure pre-
ented here is a Phe82Ala mutation that was designed to
hange the crystal interaction and produce a different
rystal form. The crystal form and the packing environ-
ent within the crystal in the present study are indeed
ifferent.
TABLE 1
Crystal Parameters and Statistics of Diffraction Data
pace group P21 (4 molecules/asymmetric unit)
nit cell a 5 50.56 Å; b 5 78.35 Å; c 5 105.29 Å
a 5 90°; b 5 97.5; g 5 90°
esolution 15.0–1.9 Å (1.96–1.9 Å)a
bservations 494,113
nique reflections 59,384 (4001)
ompleteness 92.3% (74.7%)
verage intensity I/s(I) 4.8 (1.8)
merge
b 0.033 (0.157)
a Numbers in parentheses are for highest resolution shell.
b Rmerge 5 ¥hkl (¥ iuI i 2 ^I&u/¥ iI i).
FIG. 1. Binding of the acetyl-Val-Phe inhibitor in the active site of HA
he structure of HAV 3C (C24S, F82A) acetyl-Val-Phe-amide in stereo. T
ellow. The b-strands of the N-terminal domain are colored lilac and thos
hat extends from the C-terminal domain are colored in light gray. Helice
ole are in gray. Also included are several active site residues. Helice
etters and the domain number. The active site residues are labeled w
he active site of molecule D with the covalently bound inhibitor in ste
bserved diffraction data between 15.0 and 1.9 Å and contoured at a le
hite crosses represent the positions of refined water molecules. The
eft and the residues of the oxyanion hole on the right. (c) Representativ
lectron density are similar to those in b. Figures 1a, 2, 3, 4, and 5 were
988; Esnouf, 1997; Kraulis, 1991; Merritt and Murphy, 1994).ifferences between the four molecules in the
symmetric unit
There are considerable differences among the four
olecules in the asymmetric unit (Fig. 2). There are also
ifferences in the conformations of the bound inhibitors
see below). The most prominent differences among the
our independent molecules manifest in the turns and
oops that connect the b-strands of the two domains and
re involved in the intermolecular interactions that form
he crystal. Residues 20–23, 48–53, 77–83, and 140–160
nd the C-terminus residues 214–217 constitute the re-
ions with the most significant conformational differ-
nces (Fig. 2).
Residues 77 to 83 form the loop connecting b-strands
I2 and fI. The conformation of these residues varies
mong all the molecules of HAV 3C in the crystal struc-
ures of HAV 3C. This is true for the structure presented
ere, as well as for the native structure (Bergmann et al.,
997). What determines the conformation of this loop is
he environment of the HAV 3C molecule and the inter-
olecular interactions it forms. In the crystal, these are
he intermolecular interactions that form the crystal
acking; in a cellular environment, this would likely be
ther proteins with which HAV 3C interacts. This could
TABLE 2
Refinement and Model Statistics
o. of reflections 59,384 (uFou . 0.0s and 15.0- to 1.9-Å
resolution)
o. of nonhydrogen atoms 7,228 (including 514 water molecules)
o. of degrees of freedom 28,832
-factora 0.204
ree R-factorb 0.298
oot-mean-square deviations
from ideal geometry
Bonds 0.012 Å
Bond angles 1.456°
General planes 0.025 Å
o. of w, c angle outliers 49 (6.2%)
a R 5 ¥hkl (uuFou 2 uFcuu)/¥hkluFou for 55,982 reflections used in the
efinement.
b For the 3902 reflections not used in the refinement (6.5%).
a) Ribbon representation of the secondary structure of molecule D of
nd inhibitor is included in a bond-stick representation and colored in
e C-terminal domain in cyan. The b-strands of the anti-parallel b-ribbon
olored in green and coil structures in red. The residues of the oxyanion
beled successively with capital letters and b-strands with lowercase
single-letter amino acid code. (b) Representative electron density for
e electron density maps are of the form 2Fo 2 Fc calculated with all
1.25s above the mean. The inhibitor is represented with white bonds.
into the active site with the general acid–base catalyst His D44 on the
ron density in the active site of molecule B. The coloring, view and the
red with the programs MolScript and Raster-3D (Bacon and Anderson,V 3C. (
he bou
e of th
s are c
s are la
ith the
reo. Th
vel of
view is
e elect
prepa
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158 BERGMANN ET AL.ave some significance for the polyprotein processing in
AV.
Despite the fact that residues 77 to 83 have quite
ifferent conformations in the crystal structures and it is
afe to assume that this loop can have several different
onformations in the molecule, the same does not apply
or Asp 84. Asp 84 of HAV 3C corresponds topologically
o the third member of the catalytic triad in chymotrypsin-
ike proteinases. However, in HAV 3C its side chain
annot interact with the general acid–base catalyst His
4 (Bergmann et al., 1997). The active sites of the four
olecules of HAV 3C in the crystal structure presented
ere show much more conformational variability than is
bserved in the active sites of the chymotrypsin-like
erine proteinases (Fig. 3). Nevertheless, the position of
sp 84 in all molecules from all crystal structures is the
ame within the accuracy of the experimental data. None
f the Asp 84 side chains in any of the HAV 3C structures
an interact with the general acid–base catalyst His 44,
espite the inherent flexibility of the preceding loop (res-
dues 79–83, Fig. 2). Bergmann et al. (1997) proposed that
here is no catalytic triad in HAV 3C and the observed
onformations of the Asp 84 residues in this structure
upport that conclusion.
Residues 140 to 160 extend from two of the strands of
FIG. 4. Stereo view of a superposition of molecule D of HAV 3C (C24S
acterial serine proteinase SGPB (Huang et al., 1995; PDB id-code “1sg
nzymes without the inhibitor. Carbon atoms are colored in gray (SGP
oloring code is used for N (blue), O (red) and S atoms (yellow). The
espective enzymes in the same location and a similar conformation.
FIG. 5. Stereo views of a model of the substrate sequence GLFSQ
olyprotein of a cell culture-adapted, fast-growing strain of HAV, bound
ound within the secondary structure elements of HAV 3C. The repres
a. The peptide is represented as bonds with the C atoms colored in l
s colored with C atoms in light gray, O atoms in orange, and N atoms
he residues of the oxyanion hole are in black, residues from b-strands
I are in pink, residues from b-strand bI are in lilac, and residues from
FIG. 2. Stereo view of a superposition of the Ca traces of all four
olecules of the structure of HAV 3C (C24S, F82A) acetyl-Val-Phe-
mide. The view is rotated 90° to the right with respect to Fig. 1a.
olecules A to D are shown in light gray to black. The position of the
ucleophilic active site residue Cys 172 is marked; the C-termini and
esidues from the structurally most diverse regions are labeled., F82A) acetyl-Val-Phe-amide and the structure of an inhibitor complex of the
q”). The structures were superimposed using only Ca atom coordinates of the
B) or green (HAV 3C) and the inhibitors are colored darker. The conventional
P91 and P92 residues of the two inhibitors superimpose well and bind to the
uAN, that consitutes the sequence of the primary cleavage site within the
in the active site of HAV 3C (Zhang et al., 1995). (a) The substrate sequence
entation of the secondary structure and the view are similar to those in Fig.
ight gray. (b) Details of the binding of the substrate sequence. The substrate
in light blue. The C atoms of the active site of HAV 3C are colored as follows:
bII2, eII, and fII and helix B (His 44) are in dark gray, residues from b-strand
the turn that connects b-strands aII and bII1 are in cyan. Thicker and thinnerroken lines represent hydrogen bonds with main chain and side chain atomFIG. 3. Stereo views of the active site residues with the bound
nhibitors for molecule A (a), molecule B (b), and molecule D in (c). The
ound inhibitor is highlighted with thicker bonds and colored in black.
elected hydrogen bonds are represented by broken lines and waters of the substrate sequence, respectively.
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159INHIBITOR COMPLEX OF 3C PROTEINASE FROM HEPATITIS A VIRUShe C-terminal b-barrel domain and contribute to one
ide of the active site (colored light gray in Fig. 1a). We
ave labeled this structural feature an anti-parallel b-rib-
on because it is formed by two b-strands that do not
orm part of a larger b-sheet or b-barrel, but are hydro-
en bonded only to each other (Bergmann et al., 1997).
his anti-parallel b-ribbon corresponds topologically to
he methionine loop in the chymotrypsin-like serine pro-
einases. It is also present in some bacterial chymotryp-
in-like serine proteinases, such as a-lytic proteinase,
here it is referred to as the aLP hairpin (Fujinaga et al.,
985; Sauter et al., 1998). It forms part of the specificity
ockets for the P4 and P2 residues of a substrate in the
C proteinases. In HAV 3C the anti-parallel b-ribbon is
ignificantly longer than in other 3C proteinases (Berg-
ann and James, 1999b).
In the four molecules of HAV 3C in the present struc-
ure, the conformations of the anti-parallel b-ribbon are
ignificantly different from one another and are chiefly
etermined by the intermolecular interactions in the
rystal. The reverse turn at the very tip of the hairpin is
he most flexible part, but the whole anti-parallel b-rib-
on can rotate away from the core of the molecule. This
s illustrated by the position of residue B150 in Fig. 2. In
he majority of the molecules in the crystal structures of
AV 3C, the anti-parallel b-ribbon interacts with the N-
erminal domain and contributes residues to the active
ite (Fig. 3; Bergmann et al., 1997). In molecule B of the
resent structure an intermolecular interaction causes
he anti-parallel b-ribbon to move away from the N-
erminal domain with a hinge-like motion of about 20°
Fig. 2). As a result, there is a wide gap between the
-terminal domain of HAV 3C and the anti-parallel b-rib-
on in molecule B. In the recently determined structure of
-lytic protease complexed with its prosegment, the pro-
egment causes the aLP hairpin to move away from the
ore of the molecule (Sauter et al., 1998). The proseg-
ent-induced conformational change of the aLP hairpin
n a-lytic protease resembles the change in the confor-
ation of the anti-parallel b-ribbon in molecule B of the
resent structure. This suggests that the flexibility of the
nti-parallel b-ribbon plays a role in the autocatalytic
xcision of the 3C proteinases, similar to its role in some
acterial chymotrypsin-like serine proteinases.
ctive site structure
Figure 3 shows the details of the active sites of mol-
cules A, B, and D with the bound acetyl-Val-Phe-amide
nhibitors. Conformational angles of important active site
esidues and the distances of some interactions in the
ctive site are presented in Table 3. The chemical groups
resent in the active sites of proteolytic enzymes are a
ucleophile, a general acid–base catalyst, and an elec-
rophilic feature commonly called the oxyanion hole
Brocklehurst et al., 1998; Wharton, 1998). The corre- mponding residues in HAV 3C are Cys 172 (the nucleo-
hile), His 44 (the general acid–base catalyst), and
ro169 to Cys172 (the oxyanion hole, dark gray in Fig. 1a;
ergmann et al., 1997).
Molecule D of HAV 3C acetyl-Val-Phe-amide resem-
les the native enzyme most closely (Fig. 3c). In partic-
lar the conformation and the environment of the general
cid–base residue His D44 resemble those observed in
he native enzyme (Bergmann et al., 1997). A water mol-
cule, which takes up the position of the carboxylate of
he third member of the catalytic triad in the structure of
ergmann et al. (1997), is also present in molecule D.
he side chain hydroxyl of Tyr D143 is within hydrogen
onding distance to this water molecule. The Sg atom of
he nucleophilic Cys D172, the imidazole ring of the
eneral acid–base catalyst His D44, and this water mol-
cule are in a common plane. In the native enzyme the
ide chain of Tyr 143 interacts with, and presumably
tabilizes, this arrangement. In molecules A and B of HAV
C acetyl-Val-Phe-amide, the imidazole ring of the gen-
ral acid–base catalyst His 44 is rotated out of that plane
nd away from the position where it could productively
nteract with the nucleophile Cys 172 (Figs. 3a and 3b). In
olecules A and B, Tyr 143 is part of the flexible, anti-
arallel b-ribbon of HAV 3C (light gray in Fig. 1a) and has
oved away from the active site because of crystal
acking interactions that involve residues 147 to 152.
herefore, Tyr143 cannot stabilize the conformation of
he imidazole of His 44 or the water molecule that is
ydrogen bonded to the Nd1 atom of His 44. We believe
hat the missing interaction between Tyr 143 and His 44
auses the nonproductive conformation of the imidazole
f His 44. This supports the notion that Tyr143 is impor-
ant for catalysis and helps to maintain the proper orien-
ation and possibly the protonation state of the general
cid–base catalyst His 44 in HAV 3C (Bergmann et al.,
997).
Clearly the active site of HAV 3C is much more flexible
han that of the related chymotrypsin-like serine protein-
ses. What functional significance this flexibility has is
ess obvious. The subtle conformational differences be-
ween the oxyanion holes of the molecules in the present
tructure and the native enzyme could simply be due to
he presence of an additional methylene group in the
cetyl moiety of the inhibitor, compared to the acyl-
nzyme intermediate formed by a natural substrate.
nhibitor binding and implications for substrate
ecognition by HAV 3C
The inhibitor used in the present study was designed
o interact covalently with the enzyme and to bind spe-
ifically to the S91 and S92 sites of the HAV 3C proteinase
Mckendrick et al., 1998). The covalent bond between the
g atom of the nucleophilic Cys172 residue and the
ethylene group of the acetyl portion of the inhibitor was
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160 BERGMANN ET AL.mmediately evident in the initial electron density maps
Figs. 1b and 1c). The main chain of the dipeptide inhib-
tor is bound between the oxyanion hole and the edge
trand (bI) of the N-terminal b-barrel domain (Fig. 1a).
igure 4 shows a superposition of molecule D of HAV 3C
cetyl-Val-Phe-amide onto the corresponding residues in
he structure of the complex of the bacterial chymotryp-
in-like serine proteinase SGPB and a cognate protein
nhibitor (SGPB-OMTKY3 complex, PDB ID-code “1sgq,”
uang et al., 1995).
The positions of the P91 and P92 residues in the two
tructures and the interactions between the enzymes
nd the main chain atoms of the inhibitors are very
imilar. Therefore, the acetyl-Val-Phe-amide inhibitor
oes indeed bind to the S91 and S92 sites of the proteinase,
n the manner for which it was designed (Mckendrick et
l., 1998) and in the canonical conformation that is ex-
ected for the P91 and P92 residues of a substrate of a
hymotrypsin-like proteinase (Bode and Huber, 1992; Pe-
T
Active Site Conformationsa
Pro 169 w 2
c 1
Gly 170 w
c 2
Cys 172 w 2
c 1
x1 2
His 44 x1 2
x2
Asp 84 x1 2
x2 2
Tyr 143 x1 2
x2 2
Acetyl 306 c 1
Val 307 P91 w 2
c 1
x1 21
Phe 308 P92 w 2
c 1
x1 2
x2 2
Acetyl CAO. . .Gly170 NH 2.6
Acetyl CAO. . .Cys172 NH 2.8
Val28 CAO. . .Val P91 NH 2.7
Val P91 CAO. . .Gly170 NH (3.2
His44 Ne. . .Cys172Sg (4.0
His44 Nd. . .H2O —
Tyr143 OH. . .H2O —
Asp84 CAO. . .H2O —
a All conformational angles in this table are in degrees.
b A, B, C, and D refer to the four molecules of the complex of HAV 3
c Distances listed in parentheses are not hydrogen bonds.
d Residue number of the water molecules.ona and Craik, 1995; Read and James, 1986). Details of shis conformation, the enzyme inhibitor interactions, and
he active site conformations in the four molecules in the
tructure of HAV 3C acetyl-Val-Phe-amide are listed in
able 3 and shown in Fig. 3.
The peptide bond connecting the valine and phenylal-
nine residues of the dipeptide inhibitor forms a hydro-
en bond with a peptide carbonyl (Val 28) from the edge
trand (b-bI) of the N-terminal b-barrel (Table 3; Val28
AO. . .Val P91 NH). This interaction is conserved within
nzyme substrate and enzyme inhibitor complexes of
hymotrypsin-like proteinases. The acetyl moiety of the
nhibitor binds in the oxyanion hole of the enzyme. Com-
ared to the substrate of a proteinase, the acetyl moiety
f the inhibitor has an additional methylene group. Dur-
ng the catalytic reaction of proteolytic enzymes the car-
onyl of the scissile bond forms two hydrogen bonds
nside the oxyanion hole (acetyl CAO. . .Gly170 NH and
cetyl CAO. . .Cys172 NH). These two hydrogen bonds
re believed to facilitate catalysis by orienting the scis-
zyme Inhibitor Interactions
Bb Cb Db
282 272 280
160 166 163
84 85 69
11 211 3
255 258 254
135 138 162
276 276 274
71 70 69
275 266 290
255 3 256
262 38 232
75 57 58
280 81 290
44 48 43
81 91 92
263 261 256
132 154 151
178 260 248
259 260 268
254 164 128
2176 276 269
54 240 220
(3.05 Å) 2.77 Å (3.48 Å)
2.8 Å 2.82 Å 2.93 Å
2.69 Å 2.77 Å 2.86 Å
3.22 Å 2.43 Å 2.89 Å
3.49 Å (4.05 Å) 3.54 Å
2.74 Å — 2.65 Å
(177)d (401)d
(8.1 Å) — 3.29 Å
2.99 Å — 2.87 Å
ase in the asymmetric unit.ABLE 3
and En
Ab
66
63
97
18
60
44
69
35
58
64
79
58
85
30
09
97
19
61
34
25
65
47
7 Å
1 Å
3 Å
7 Å)c
5 Å)
C proteile bond for the nucleophilic attack, stabilizing the de-
v
a
t
h
t
p
c
b
t
i
h
e
m
s
l
2
t
T
H
s
t
s
r
c
a
t
e
b
(
P
a
(
l
p
h
b
a
p
(
c
a
n
l
n
p
P
c
t
S
r
R
c
F
T
a
G
w
s
c
r
w
t
a
a
c
m
(
a
t
c
t
n
t
b
S
c
J
I
p
1
f
i
c
c
t
o
p
i
f
d
v
b
w
v
w
1
b
i
P
a
w
o
161INHIBITOR COMPLEX OF 3C PROTEINASE FROM HEPATITIS A VIRUSeloping negative charge of the tetrahedral intermediate,
nd facilitating charge separation during the formation of
he new bond in the acyl-enzyme intermediate (Brockle-
urst et al., 1998; Wharton, 1998). The carbonyl group of
he acetyl moiety in the four molecules in the structure
resented here is slightly rotated toward the nucleophilic
ysteine to accommodate the additional methylene car-
on of the acetyl group (Table 3 and Fig. 3). As a result,
he oxygen of the carbonyl of the acetyl moiety of the
nhibitor is not centered in the oxyanion hole and only the
ydrogen bond to the amide of Cys 172 shows the
xpected geometry for a good hydrogen bond (Table 3).
The valine side chain in the P91 position of the inhibitor
akes nonspecific hydrophobic interactions with the
ide chains of Val 28 and Met 29 of the enzyme. Both
ow-energy conformations of a valine side chain (g1 ;
60.0° and t ; 180°, Janin et al., 1978) are observed in
he inhibitor molecules of the present structure (Fig. 3,
able 3; Val 307 P91 x1). There is no defined S91 pocket in
AV 3C. This correlates well with the fact that compari-
ons of the sequences of natural cleavage sites within
he HAV polyprotein does not reveal a preference for a
pecific amino acid residue in P91 (Bergmann, 1998, and
eferences therein, Seipelt et al., 1999).
In three of the four molecules in this structure, the side
hain of the phenylalanine residue in the P92 position is in
g1 conformation; it fits into a pocket formed between
he two first b-strands of the N-terminal domain of the
nzyme, the reverse turn that connects b-strands aII and
II1 in the C-terminal domain and the oxyanion hole
Figs. 1a and b). In molecule B, the side chain of the P92
he is in its second possible low-energy conformation (t)
nd does not reach into the S92 pocket of the enzyme
Figs. 1c and 3b). An intermolecular interaction with a
ysine side chain from an adjacent molecule (Lys C106)
resumably causes this unique conformation of the in-
ibitor side chain in molecule B. A water molecule is
ound in the S92 pocket of molecule B.
The lowest energy conformations for the two dihedral
ngles, which define the side chain conformation of a
henylalanine residue, are x1 5 260° (g
1) and x2 5 90°
t) (Janin et al., 1978). Whereas the phenylalanine side
hains of the inhibitors bound in the S92 pocket of HAV 3C
re close to a x1 g
1 conformation, the aromatic ring does
ot fit into this pocket without being rotated away from its
ow-energy conformation. The x2 angles of the P92 phe-
ylalanine residues, which are bound in the S92 specificity
ocket, are significantly different from 90° (Table 3;
he308 P92 x2). The aromatic ring of the inhibitor side
hain also forces a slight rotation of the peptide bond
hat connects Met 29 and Gln 30 of HAV 3C to fit into the
92 pocket in the enzyme. The corresponding methionine
esidues (A29, C29, and D29) are flagged as outliers in a
amachandran plot. Therefore, the phenylalanine side
hain is not a perfect fit for the S92 pocket of the enzyme.
urthermore, the S92 pocket of HAV 3C is not hydrophobic. phere are numerous potential hydrogen-bond donors
nd/or acceptors (Gln 15, Asn 30, Thr 122, Asp 124, and
ly170) that line the pocket. In molecule B a well-refined
ater molecule is bound in place of the phenylalanine
ide chain (Figs. 1c and 3b).
Because of the chemical reactivity of some of the side
hains it was not possible to include all amino acid
esidues in the study of Mckendrick et al. (1998). Lysine,
hich is the P92 residue of the primary cleavage site of
he HAV polyprotein (Martin et al., 1995; Schultheiss et
l., 1994, 1995b), could not be included. One of the amino
cid substitutions that distinguish a fast-growing, cell
ulture-adapted strain of HAV is a lysine to asparagine
utation in the P92 position of the primary cleavage site
GLFSQuAKI to GLFSQuANI, Zhang et al., 1995). A P92
sparagine residue was also not present in any of the
ested inhibitors. Modeling studies indicate that the side
hain of an asparagine residue would be the best fit for
he S92 pocket of HAV 3C. Its size would allow it to fit
icely into the pocket in its lowest side chain conforma-
ion and at the same time it could form several hydrogen
onds (Fig. 5). A lysine residue would also fit well into the
92 pocket because its side chain is more flexible and it
ould donate several hydrogen bonds (Bergmann and
ames, 1999a).
The defined S92 pocket is a unique feature of HAV 3C.
t does not exist in the structures of other picornaviral 3C
roteinases (Matthews et al., 1994; Mosimann et al.,
997). Therefore, and because asparagine is the best fit
or the S92 pocket of HAV 3C, we suggest that the residue
n the P92 position plays a role in the differentiation of the
leavage sites in the HAV polyprotein. Among HAV 3C
leavage sites with the general sequence XL/IX
S/TQuXXX,
he fit of the P92 residue into the corresponding S92 pocket
f HAV 3C would be an important factor to select the
rimary cleavage sites. According to our modeling stud-
es, asparagine is the best fit for the S92 pocket of HAV 3C.
MATERIALS AND METHODS
The double-mutant C24S, F82A of HAV 3C was purified
rom a bacterial overexpression system as previously
escribed (Malcolm et al., 1992). The inhibitor iodoacetyl-
alyl-phenylalanylamide was synthesized as described
y Mckendrick et al. (1998). Purified HAV 3C (C24S, F82A)
as incubated with a fivefold molar excess of iodoacetyl-
alyl-phenylalanylamide and the formation of a complex
as confirmed by mass spectroscopy (Mckendrick et al.,
998). The crystals of the inhibitor complex were grown
y the hanging-drop vapor diffusion method. The hang-
ng drops were prepared from 2 ml of HAV 3C acetyl-Val-
he-amide complex at 10 mg/ml in 10 mM Tris, pH 7.5,
nd 6 ml of the reservoir solution. The hanging drops
ere equilibrated against a reservoir solution consisting
f 1 ml of 100 mM Tris, pH 8.5, 5% DMSO, and 18%
olyethylene glycol 8000. Crystals were transferred by
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162 BERGMANN ET AL.erial transfer into a similar solution with an additional
5–20% glycerol over a period of a few minutes. Diffrac-
ion data were collected at beam line 7-1 of the Stanford
ynchrotron Radiation Laboratory at a crystal tempera-
ure of 100 K. The data were processed with the HKL data
rocessing suite of programs (Otwinowski and Minor,
997) and all further calculations utilized the programs of
he CCP4 suite of crystallographic programs (Collabora-
ive Computational Project No. 4, 1994). The structure
as solved by the method of molecular replacement
Rossmann, 1990) with the program package AMoRe
Navaza, 1994) and using molecule A of the structure of
he native enzyme (Bergmann et al., 1997) as a search
odel. Initial refinement was performed with a version of
he program X-Plor (Bru¨nger, 1993), which had an imple-
entation of a maximum-likelihood refinement target
Pannu and Read, 1996). The final cycles of refinement
ere performed with the program package TNT (Tronrud
t al., 1987; Tronrud, 1992). All model building and graph-
cal manipulation were performed with the program O
Jones et al., 1991; Jones and Kjeldgaard, 1995). The
igures were prepared with the programs Bobscript (Es-
ouf, 1997; Kraulis, 1991) and Raster-3D (Bacon and
nderson, 1988; Merritt and Murphy, 1994). The coordi-
ates of HAV 3C acetyl-Val-Phe-amide have been depos-
ted with the Protein Data Bank (PDB ID-code “1qa7”).
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